Free Trial

Sarepta Therapeutics (SRPT) Insider Trading & Ownership

Sarepta Therapeutics logo
$74.10 +0.65 (+0.88%)
Closing price 03/21/2025 04:00 PM Eastern
Extended Trading
$74.04 -0.05 (-0.07%)
As of 03/21/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sarepta Therapeutics (NASDAQ:SRPT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.70%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$4.96 M
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$10.67 M
Get SRPT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Sarepta Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SRPT Insider Buying and Selling by Quarter

Remove Ads

Sarepta Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/12/2025Claude NicaiseDirectorSell2,491$99.64$248,203.24  
12/12/2024Hans Lennart Rudolf WigzellDirectorSell10,500$124.84$1,310,820.00  
12/5/2024Kathryn Jean BoorDirectorSell1,636$125.55$205,399.80  
8/30/2024Ian Michael EstepanCFOSell5,985$137.36$822,099.60  
8/16/2024Michael Andrew ChambersDirectorBuy37,038$133.80$4,955,684.40  
6/25/2024Ryan Edward BrownEVPSell38,957$161.61$6,295,840.77  
6/24/2024Bilal ArifInsiderSell7,859$163.08$1,281,645.72  
5/2/2024Dallan MurrayInsiderSell3,635$140.00$508,900.00  
(Data available from 1/1/2013 forward)

SRPT Insider Trading Activity - Frequently Asked Questions

7.70% of Sarepta Therapeutics stock is owned by insiders. Learn more on SRPT's insider holdings.

The following insiders have purchased SRPT shares in the last 24 months: Douglas S Ingram ($2,001,856.00), Michael Andrew Chambers ($9,749,217.58), and Richard Barry ($3,940,500.00).

Insiders have purchased a total of 157,109 SRPT shares in the last 24 months for a total of $15,691,573.58 bought.

The following insiders have sold SRPT shares in the last 24 months: Bilal Arif ($1,539,325.72), Claude Nicaise ($248,203.24), Dallan Murray ($508,900.00), Hans Lennart Rudolf Wigzell ($4,760,370.00), Ian Michael Estepan ($976,059.60), Kathryn Jean Boor ($298,949.53), Ryan Edward Brown ($6,295,840.77), and Stephen Mayo ($385,479.60).

Insiders have sold a total of 108,159 Sarepta Therapeutics shares in the last 24 months for a total of $15,013,128.46 sold.

Sarepta Therapeutics Key Executives



This page (NASDAQ:SRPT) was last updated on 3/23/2025 by MarketBeat.com Staff
From Our Partners